Moderna Inc. buy UBS Group AG
Start price
08.01.25
/
50%
€43.07
Target price
08.01.26
€93.16
Performance (%)
-40.85%
Price
15.12.25
€25.48
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG for Moderna Inc. is performing very badly with a performance of -40.85%. This prediction currently runs until 08.01.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Moderna Inc. | 5.969% | 5.969% |
| iShares Core DAX® | 0.795% | 1.458% |
| iShares Nasdaq 100 | -3.088% | -0.762% |
| iShares Nikkei 225® | -0.952% | -2.268% |
| iShares S&P 500 | -1.393% | 0.199% |
Comments by UBS_Group_AG for this prediction
In the thread Moderna Inc. diskutieren
Moderna, Inc. (NASDAQ: MRNA) had its price target lowered by analysts at UBS Group AG from $108.00 to $96.00. They now have a "buy" rating on the stock.
Ratings data for MRNA provided by MarketBeat